Intellia Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of NTLA for the last quarter is 28.93 M USD, and it's 1609.39% higher compared to the previous quarter. The net income of Q1 24 is -107.44 M USD.